NYLIM
SRRA

New York Life Investment Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

New York Life Investment Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-16,702
Closed -$918K – 1287
2022
Q2 		$918K Buy
+16,702
New +$876K 0.01% 632

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return

New York Life Investment Management's SRRA Position: Q3 2022 in Review

New York Life Investment Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 16,702 shares — an estimated $918K sold.

New York Life Investment Management first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $918K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • New York Life Investment Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • New York Life Investment Management sold 16,702 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $918K.
  • New York Life Investment Management first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • New York Life Investment Management's Sierra Oncology, Inc. Common Stock position peaked at $918K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on New York Life Investment Management's 13F filing for Q3 2022, filed 10 Nov 2022.